Intervention aims to improve haematopoietic recovery and survival in elderly cancer patients by targeting stem cell niche functions.
Rejuvenating the blood: a new intervention targeting RhoA nuclear mechanoactivity in aged haematopoietic stem cells Elderly cancer patients suffer high haematopoietic toxicity upon chemotherapy. ReSinAge aims to boost haematopoietic recovery and increase the survival after chemotherapy in the elderly by improving the regenerative capacity of the aged haematopoietic stem cell niche. In detail, we aim to disclose the functional interplay between blood stem cells and their niche, and its targeting as an innovative strategy to overcome chemotherapy toxicity and increase the survival of elderly cancer patients.
No takes yet. Share an insight, caveat, or question.
Carolina Florian (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: